UBS AM
OMIC

UBS AM’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

UBS AM’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,733
Closed -$1.12M – 2783
2022
Q2 		$1.12M Sell
9,733
-3,334
-26% -$391K ﹤0.01% 1894
2022
Q1 		$2.47M Sell
13,067
-6,352
-33% -$1.47M ﹤0.01% 1692
2021
Q4 		$6.73M Sell
19,419
-909
-4% -$352K ﹤0.01% 1277
2021
Q3 		$6.82M Buy
20,328
+3,119
+18% +$1.6M ﹤0.01% 1234
2021
Q2 		$14.2M Buy
+17,209
New +$13.3M 0.01% 990

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

UBS AM's OMIC Position: Q3 2022 in Review

UBS AM sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2022, closing a stake of 9,733 shares — an estimated $1.12M sold.

UBS AM first reported a position in OMIC in Q2 2021 and held it in 5 quarters. The position peaked at $14.2M in Q2 2021. 74 funds tracked by Wall St. Rank hold OMIC as of Q3 2022.

  • UBS AM reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • UBS AM sold 9,733 Singular Genomics Systems, Inc. Common Stock shares in Q3 2022, an estimated $1.12M.
  • UBS AM first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • UBS AM's Singular Genomics Systems, Inc. Common Stock position peaked at $14.2M in Q2 2021.
  • 74 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2022.

Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.